Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Newcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma
Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice
Hyperthermia and Radiation Therapy in Locoregional Recurrent Breast Cancers: A Systematic Review and Meta-analysis
Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model
Dendritic Cell-Based Adjuvant Vaccination Targeting Wilms‘ Tumor 1 in Patients with Advanced Colorectal Cancer
A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells
Clinical research on dendritic cell vaccines to prevent postoperative recurrence and metastasis of liver cancer
HIV immunotherapy comes of age: implications for prevention, treatment and cure
Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies
Oncolytic newcastle disease virus triggers cell death of lung cancer spheroids and is enhanced by pharmacological inhibition of autophagy
Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
Reirradiation and hyperthermia for irresectable locoregional recurrent breast cancer in previously irradiated area: Size matters
Hyperthermia: an effective strategy to induce apoptosis in cancer cells
Oncolysis by paramyxoviruses: preclinical and clinical studies
Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity
Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy
Bericht von Prof. Dr. Schirrmacher im International Journal of Oncology zu den Erkenntnissen der Tumor-reaktiven T-Zell-Memory im Knochenmark
Validity of combination active specific immunotherapy for colorectal cancer: a meta-analysis of 2993 patients
Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance